The potency assay is a sudden fixation of the FDA and a side-issue and resolved after some careful lab work.
All MSB has had to do is resolve the precision inconsistencies, and then do the batch testing this is process not substance.
An obvious but key point: It's not about efficacy of remestemcel-L is it?
(whytee is always getting this wrong IDK what to do about her misconceptions whether they'r deliberate or just from limited intelligence, but I guess it's irrelevant. but with you it's fear-based and that's different, she's simply feeding the fear).
SI patiently explained the difference at the AGM and this has been spelled out multiple times in here.
Ann: Trading Halt, page-86
-
- There are more pages in this discussion • 631 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.16 | $3.150M | 2.649M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 4860 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 18204 | 9 |
View Market Depth
| Last trade - 12.21pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |